{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:15:22Z","timestamp":1768565722730,"version":"3.49.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ncl.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T18:12:57Z","timestamp":1569435177000},"page":"771-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inpatient Management of Migraine"],"prefix":"10.1016","volume":"37","author":[{"given":"Michael J.","family":"Marmura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40265-018-0865-y","article-title":"Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs","volume":"78","author":"Ong","year":"2018","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","article-title":"Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life","volume":"84","author":"Buse","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2019.07.007_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1992.03480010072027","article-title":"Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors","volume":"267","author":"Stewart","year":"1992","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ncl.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1177\/0333102411425960","article-title":"Costs associated with outpatient, emergency room and inpatient care for migraine in the USA","volume":"31","author":"Insinga","year":"2011","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.ncl.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1526-4610.2007.00846.x","article-title":"Less is not more: underutilization of headache medications in a university hospital emergency department","volume":"47","author":"Gupta","year":"2007","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.ncl.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/head.13387","article-title":"American Headache Society survey about urgent and emergency management of headache patients","volume":"58","author":"Minen","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib7","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]","article-title":"Headaches in U.S. hospitals and emergency departments, 2008: Statistical Brief #111","author":"Lucado","year":"2011"},{"issue":"33","key":"10.1016\/j.ncl.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1526-4610.1993.hed3302055.x","article-title":"Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study","author":"Lake","year":"1993","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.50.6.1741","article-title":"Migraine and reduced work performance: a population-based diary study","volume":"50","author":"VonKorff","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pain.2009.01.013","article-title":"Excessive opioid use and the development of chronic migraine","volume":"142","author":"Bigal","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.ncl.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1526-4610.2008.01153.x","article-title":"Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines","volume":"48","author":"Saper","year":"2008","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0333102413477737","article-title":"Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the 'CARE' protocol)","volume":"33","author":"Sances","year":"2013","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1526-4610.2004.04093.x","article-title":"Inpatient treatment of headache: an evidence-based assessment","volume":"44","author":"Freitag","year":"2004","journal-title":"Headache"},{"issue":"12","key":"10.1016\/j.ncl.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1468-2982.2005.00980.x","article-title":"Efficacy of multidisciplinary treatment in a tertiary referral headache centre","volume":"25","author":"Zeeberg","year":"2005","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ncl.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0333102411409075","article-title":"Integrated headache care","volume":"31","author":"Diener","year":"2011","journal-title":"Cephalalgia"},{"issue":"20","key":"10.1016\/j.ncl.2019.07.007_bib17","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.9734\/BJMMR\/2014\/9111","article-title":"Emergency and inpatient treatment of migraine: an American Headache Society survey","volume":"4","author":"Dougherty","year":"2014","journal-title":"Br J Med Med Res"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3949\/ccjm.64.7.373","article-title":"Standards of care for treating headache in primary care practice. National Headache Foundation","volume":"64","author":"Solomon","year":"1997","journal-title":"Cleveland Clinic J Med"},{"key":"10.1016\/j.ncl.2019.07.007_bib19","first-page":"1","article-title":"Handbook of headache management: a practical guide to diagnosis and treatment of head, neck, and facial pain","author":"Saper","year":"1999"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11916-011-0178-2","article-title":"Diagnosis of acute headache","volume":"15","author":"Nahas","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1526-4610.2007.01052.x","article-title":"The child with headache in a pediatric emergency department","volume":"48","author":"Conicella","year":"2008","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1037\/hea0000272","article-title":"Diagnostic uncertainty, guilt, mood, and disability in back pain","volume":"35","author":"Serbic","year":"2016","journal-title":"Health Psychol"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1526-4610.2011.01995.x","article-title":"Naming migraine and those who have it","volume":"52","author":"Young","year":"2012","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.ncl.2019.07.007_bib24","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/jnnp.2004.057851","article-title":"Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache","volume":"76","author":"Howard","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.ncl.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/head.13118","article-title":"Multidisciplinary team treatment approaches to chronic daily headaches","volume":"57","author":"Sahai-Srivastava","year":"2017","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11916-015-0531-y","article-title":"Update of inpatient treatment for refractory chronic daily headache","volume":"20","author":"Lai","year":"2016","journal-title":"Curr Pain Headache Rep"},{"issue":"11","key":"10.1016\/j.ncl.2019.07.007_bib27","first-page":"867","article-title":"Medication overuse headache: history, features, prevention and management strategies","volume":"27","author":"Saper","year":"2013","journal-title":"CNSDrugs"},{"key":"10.1016\/j.ncl.2019.07.007_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4610.1986.hed2604189.x","article-title":"Inpatient treatment of headache: long-term results","volume":"26","author":"Diamond","year":"1986","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1526-4610.2009.01364.x","article-title":"Comprehensive inpatient treatment of refractory chronic daily headache","volume":"49","author":"Lake","year":"2009","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2019.07.007_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1526-4610.2012.02133.x","article-title":"Advanced interventions for headache","volume":"52","author":"Tepper","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib31","first-page":"A14","article-title":"Stratified care is a more effective migraine treatment strategy than stepped care: results of a randomized clinical trial","volume":"54","author":"Lipton","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.07.007_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.36.7.995","article-title":"Repetitive intravenous dihydroergotamine as therapy for intractable migraine","volume":"36","author":"Raskin","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.07.007_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1526-4610.1990.hed3006334.x","article-title":"Repetitive intravenous DHE in the treatment of refractory headache","volume":"30","author":"Silberstein","year":"1990","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1526-4610.1992.hed3209439.x","article-title":"Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE","volume":"32","author":"Silberstein","year":"1992","journal-title":"Headache"},{"issue":"20","key":"10.1016\/j.ncl.2019.07.007_bib35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","article-title":"Intravenous dihydroergotamine for inpatient management of refractory primary headaches","volume":"77","author":"Nagy","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1468-2982.2006.01073.x","article-title":"Outcome of medication overuse headache after abrupt in-patient withdrawal","volume":"26","author":"Relja","year":"2006","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11940-011-0150-9","article-title":"Use of dopamine antagonists in treatment of migraine","volume":"14","author":"Marmura","year":"2012","journal-title":"Curr Treat Options Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2019.07.007_bib38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/WNL.0000000000002406","article-title":"Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome","volume":"86","author":"Eller","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1526-4610.1997.3703129.x","article-title":"Continuous intravenous dihydroergotamine in the treatment of intractable headache","volume":"37","author":"Ford","year":"1997","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1212\/WNL.45.3.577","article-title":"Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology","volume":"45","author":"Silberstein","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11916-009-0048-3","article-title":"Overuse of acute migraine medications and migraine chronification","volume":"13","author":"Bigal","year":"2009","journal-title":"Curr Pain Headache Rep"},{"issue":"12","key":"10.1016\/j.ncl.2019.07.007_bib43","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1212\/WNL.0b013e3181f39a11","article-title":"Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache","volume":"75","author":"Weatherall","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2019.07.007_bib44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.0000000000000223","article-title":"Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine","volume":"82","author":"Friedman","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib45","first-page":"418","article-title":"Which is more effective for the treatment of acute migraine attack: dexketoprofen, ibuprofen or metoclopramide?","volume":"34","author":"Karacabey","year":"2018","journal-title":"Pakistan J Med Sci"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1468-2982.2002.00364.x","article-title":"Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study","volume":"22","author":"Bigal","year":"2002","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1526-4610.2001.111006171.x","article-title":"Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks","volume":"41","author":"Demirkaya","year":"2001","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S1481803500009593","article-title":"Intravenous magnesium for acute benign headache in the emergency department: a randomized double-blind placebo-controlled trial","volume":"6","author":"Frank","year":"2004","journal-title":"CJEM"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-2982.2004.00840.x","article-title":"A\u00a0randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department","volume":"25","author":"Cete","year":"2005","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(99)00220-6","article-title":"A\u00a0prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches","volume":"18","author":"Ginder","year":"2000","journal-title":"J\u00a0Emerg Med"},{"issue":"6","key":"10.1016\/j.ncl.2019.07.007_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1526-4610.2002.02127.x","article-title":"Intravenous valproate sodium in the treatment of daily headache","volume":"42","author":"Schwartz","year":"2002","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1526-4610.2004.04010.x","article-title":"Treatment of primary headache disorders with intravenous valproate: initial outpatient experience","volume":"44","author":"Stillman","year":"2004","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10194-007-0378-7","article-title":"Role of intravenous levetiracetam in status migrainosus","volume":"8","author":"Farooq","year":"2007","journal-title":"J\u00a0Headache Pain"},{"issue":"11","key":"10.1016\/j.ncl.2019.07.007_bib54","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0333102414566200","article-title":"The place of corticosteroids in migraine attack management: a 65-year systematic review with pooled analysis and critical appraisal","volume":"35","author":"Woldeamanuel","year":"2015","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1526-4610.2006.00636.x","article-title":"Steroids and aseptic osteonecrosis (AON) in migraine patients","volume":"47","author":"Hussain","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib56","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"Bmj"},{"issue":"7\u20138","key":"10.1016\/j.ncl.2019.07.007_bib57","first-page":"321","article-title":"Serum beta-endorphin increase after intravenous histamine treatment of chronic daily headache","volume":"88","author":"Anselmi","year":"1997","journal-title":"Recenti Prog Med"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjp.0704842","article-title":"Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels","volume":"137","author":"Akerman","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/head.13164","article-title":"Histamine and migraine","volume":"58","author":"Yuan","year":"2018","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jama.1941.02820050021005","article-title":"The use of histamine in the treatment of specific types of headaches","volume":"116","author":"Horton","year":"1941","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11916-005-0077-5","article-title":"Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache","volume":"9","author":"Swidan","year":"2005","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"10.1016\/j.ncl.2019.07.007_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1468-2982.2003.00623.x","article-title":"Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse","volume":"23","author":"Williams","year":"2003","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/head.13298","article-title":"The use and method of action of intravenous lidocaine and its metabolite in headache disorders","volume":"58","author":"Berk","year":"2018","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib64","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2008.01281.x","article-title":"Intravenous lidocaine in the treatment of refractory headache: a retrospective case series","volume":"49","author":"Rosen","year":"2009","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ncl.2019.07.007_bib65","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1526-4610.2008.01234.x","article-title":"Mexiletine for refractory chronic daily headache: a report of nine cases","volume":"48","author":"Marmura","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib66","first-page":"1399","article-title":"Neuropsychiatric side effects of lidocaine: examples from the treatment of headache and a review","volume":"26","author":"Gil-Gouveia","year":"2006","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.ncl.2019.07.007_bib67","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jama.1989.03420080094038","article-title":"Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache","volume":"261","author":"Jones","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2009.11.020","article-title":"A\u00a0prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department","volume":"56","author":"Kostic","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"20","key":"10.1016\/j.ncl.2019.07.007_bib69","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1212\/WNL.0000000000004642","article-title":"Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine","volume":"89","author":"Friedman","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2019.07.007_bib70","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mem.2003.195","article-title":"Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial","volume":"41","author":"Tanen","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.07.007_bib72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1526-4610.1997.3706377.x","article-title":"Droperidol treatment of status migrainosus and refractory migraine","volume":"37","author":"Wang","year":"1997","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1526-4610.2006.00438.x","article-title":"Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study","volume":"46","author":"Honkaniemi","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2019.07.007_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jnnp.43.4.369","article-title":"A\u00a0double blind study of metoclopramide in the treatment of migraine attacks","volume":"43","author":"Tfelt-Hansen","year":"1980","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2019.07.007_bib75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1526-4610.1991.hed3108523.x","article-title":"Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches","volume":"31","author":"Klapper","year":"1991","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0736-4679(02)00502-4","article-title":"Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial","volume":"23","author":"Bigal","year":"2002","journal-title":"J\u00a0Emerg Med"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1553-2712.1995.tb03596.x","article-title":"Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache","volume":"2","author":"Cameron","year":"1995","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ncl.2019.07.007_bib78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0196-0644(89)80570-0","article-title":"Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache","volume":"18","author":"Lane","year":"1989","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/PEC.0000000000000718","article-title":"Relative effectiveness of dopamine antagonists for pediatric migraine in the emergency department","volume":"34","author":"Sheridan","year":"2018","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajem.2014.09.048","article-title":"Risk factors for QT prolongation associated with acute psychotropic drug overdose","volume":"33","author":"Miura","year":"2015","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14740338.2016.1161021","article-title":"Cardiovascular safety of antipsychotics: a clinical overview","volume":"15","author":"Polcwiartek","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib82","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1526-4610.2005.05074.x","article-title":"Neuroleptics in headache","volume":"45","author":"Siow","year":"2005","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib83","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jemermed.2006.05.009","article-title":"Intravenous Zofran for headache","volume":"31","author":"Gruppo","year":"2006","journal-title":"J\u00a0Emerg Med"},{"issue":"9","key":"10.1016\/j.ncl.2019.07.007_bib84","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s12630-010-9350-0","article-title":"Ondansetron-induced migraine-type headache","volume":"57","author":"Singh","year":"2010","journal-title":"Can J Anaesth"},{"issue":"15","key":"10.1016\/j.ncl.2019.07.007_bib85","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/WNL.0000000000003206","article-title":"Aprepitant for the management of nausea with inpatient IV dihydroergotamine","volume":"87","author":"Chou","year":"2016","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.ncl.2019.07.007_bib86","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1212\/WNL.0000000000003429","article-title":"Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache","volume":"87","author":"Robbins","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib87","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1526-4610.2000.00032.x","article-title":"Intravenous propofol: unique effectiveness in treating intractable migraine","volume":"40","author":"Krusz","year":"2000","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.ncl.2019.07.007_bib88","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5811\/westjem.2013.7.18081","article-title":"Sedative dosing of propofol for treatment of migraine headache in the emergency department: a case series","volume":"14","author":"Mosier","year":"2013","journal-title":"West J EmergMed"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib89","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2002.02151.x","article-title":"Intravenous propofol in the treatment of refractory headache","volume":"42","author":"Mendes","year":"2002","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1865-1380-5-19","article-title":"Improvement of refractory migraine headache by propofol: case series","volume":"5","author":"Soleimanpour","year":"2012","journal-title":"Int J EmergMed"},{"issue":"8","key":"10.1016\/j.ncl.2019.07.007_bib91","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/papr.12230","article-title":"The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical trial","volume":"15","author":"Moshtaghion","year":"2015","journal-title":"Pain practice"},{"key":"10.1016\/j.ncl.2019.07.007_bib92","first-page":"114","article-title":"Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial","volume":"12","author":"Soleimanpour","year":"2012","journal-title":"BMCNeurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10194-016-0700-3","article-title":"Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series","volume":"17","author":"Lauritsen","year":"2016","journal-title":"J\u00a0Headache Pain"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/da.22875","article-title":"Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression","volume":"36","author":"Salloum","year":"2019","journal-title":"Depress Anxiety"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/head.13013","article-title":"Ketamine infusions for treatment refractory headache","volume":"57","author":"Pomeroy","year":"2017","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.ncl.2019.07.007_bib96","doi-asserted-by":"crossref","first-page":"952","DOI":"10.5811\/westjem.2018.8.37875","article-title":"Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial","volume":"19","author":"Etchison","year":"2018","journal-title":"The West J Emerg Med"},{"issue":"1 Pt 1","key":"10.1016\/j.ncl.2019.07.007_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/peds.90.1.5","article-title":"Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department","volume":"90","author":"Nelson","year":"1992","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/088307388700200104","article-title":"Headache and acute illness in children","volume":"2","author":"Kandt","year":"1987","journal-title":"J\u00a0Child Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1526-4610.2000.00029.x","article-title":"Acute headache in children and adolescents presenting to the emergency department","volume":"40","author":"Lewis","year":"2000","journal-title":"Headache"},{"issue":"Suppl 11","key":"10.1016\/j.ncl.2019.07.007_bib100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0333102491011S1165","article-title":"Treatment of acute childhood migraine headaches","volume":"11","author":"Linder","year":"1991","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib101","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2008.01293.x","article-title":"Inpatient treatment of status migraine with dihydroergotamine in children and adolescents","volume":"49","author":"Kabbouche","year":"2009","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ncl.2019.07.007_bib102","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/0009922813492879","article-title":"Intravenous dihydroergotamine therapy for pediatric abdominal migraines","volume":"52","author":"Raina","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"issue":"8","key":"10.1016\/j.ncl.2019.07.007_bib103","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/PCC.0000000000001629","article-title":"Safety and efficacy of IV lidocaine in the treatment of children and adolescents with status migraine","volume":"19","author":"Ayulo","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib104","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jemermed.2018.01.003","article-title":"Low-dose propofol for pediatric migraine: a prospective, randomized controlled trial","volume":"54","author":"Sheridan","year":"2018","journal-title":"J\u00a0Emerg Med"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jemermed.2013.08.049","article-title":"Intravenous magnesium as acute treatment for headaches: a pediatric case series","volume":"46","author":"Gertsch","year":"2014","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096383","article-title":"The effectiveness of hospitalization in the treatment of paediatric idiopathic headache patients","volume":"40","author":"Lanzi","year":"2007","journal-title":"Psychopathology"},{"issue":"2","key":"10.1016\/j.ncl.2019.07.007_bib107","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/AJP.0b013e318185c1c9","article-title":"Effectiveness of a 3-week multimodal inpatient pain treatment for adolescents suffering from chronic pain: statistical and clinical significance","volume":"25","author":"Hechler","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ncl.2019.07.007_bib108","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpeds.2016.08.050","article-title":"Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay?","volume":"179","author":"Sheridan","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib109","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0333102410387678","article-title":"Medication adaptation headache","volume":"31","author":"Solomon","year":"2011","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1177\/0333102417728244","article-title":"A\u00a0systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache","volume":"38","author":"Cargnin","year":"2018","journal-title":"Cephalalgia"},{"issue":"39","key":"10.1016\/j.ncl.2019.07.007_bib111","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1523\/JNEUROSCI.3804-12.2013","article-title":"Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex","volume":"33","author":"Riederer","year":"2013","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib112","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0333102412467512","article-title":"Medication-overuse headache and opioid-induced hyperalgesia: a review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment","volume":"33","author":"Johnson","year":"2013","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2019.07.007_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90370-0","article-title":"Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal","volume":"254","author":"Kosten","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ncl.2019.07.007_bib114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A\u00a0phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug and alcohol dependence"},{"issue":"3","key":"10.1016\/j.ncl.2019.07.007_bib115","first-page":"142","article-title":"Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial","volume":"9","author":"Amiri","year":"2014","journal-title":"Iranian J Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100739","article-title":"The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans","volume":"157","author":"Bisaga","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02244345","article-title":"Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats","volume":"113","author":"Harris","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"issue":"6493","key":"10.1016\/j.ncl.2019.07.007_bib118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/371155a0","article-title":"Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome","volume":"371","author":"Harris","year":"1994","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ncl.2019.07.007_bib119","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1046\/j.1526-4610.2001.01189.x","article-title":"Butalbital in the treatment of headache: history, pharmacology, and efficacy","volume":"41","author":"Silberstein","year":"2001","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2019.07.007_bib120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10194-011-0364-y","article-title":"Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache","volume":"12","author":"Gaul","year":"2011","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.ncl.2019.07.007_bib121","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","article-title":"Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1526-4610.2009.01557.x","article-title":"Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification","volume":"50","author":"Tietjen","year":"2010","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ncl.2019.07.007_bib123","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AJP.0b013e31829a4d11","article-title":"Prognostic factors for pain relief and functional improvement in chronic pain after inpatient rehabilitation","volume":"30","author":"Fuss","year":"2014","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib124","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1526-4610.2009.01459.x","article-title":"Obesity and migraine: the effect of age, gender and adipose tissue distribution","volume":"50","author":"Peterlin","year":"2010","journal-title":"Headache"},{"issue":"13","key":"10.1016\/j.ncl.2019.07.007_bib125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e318212ab1e","article-title":"Improvement of migraine headaches in severely obese patients after bariatric surgery","volume":"76","author":"Bond","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3959(97)00146-2","article-title":"Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain","volume":"74","author":"McCracken","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.ncl.2019.07.007_bib127","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10879-016-9328-5","article-title":"A\u00a0comprehensive examination of changes in psychological flexibility following acceptance and commitment therapy for chronic pain","volume":"46","author":"Scott","year":"2016","journal-title":"J\u00a0Contemp Psychother"},{"issue":"7","key":"10.1016\/j.ncl.2019.07.007_bib128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jhm.2576","article-title":"Predictors of patient satisfaction with inpatient hospital pain management across the United States: a national study","volume":"11","author":"McFarland","year":"2016","journal-title":"J\u00a0Hosp Med"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2019.07.007_bib129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10072-014-1736-2","article-title":"Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review","volume":"35","author":"Raggi","year":"2014","journal-title":"Neurol Sci"},{"issue":"10","key":"10.1016\/j.ncl.2019.07.007_bib130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/sleep\/33.10.1323","article-title":"Sleep disturbances as a predictor of cause-specific work disability and delayed return to work","volume":"33","author":"Salo","year":"2010","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.ncl.2019.07.007_bib131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10926-008-9121-8","article-title":"A systematic review of the factors which predict return to work for people suffering episodes of poor mental health","volume":"18","author":"Blank","year":"2008","journal-title":"J Occup Rehabil"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919300672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919300672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:16:26Z","timestamp":1760004986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861919300672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0733861919300672"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2019.07.007","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient Management of Migraine","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}